Pancreatic Tumor
A pancreatic tumor is an abnormal growth in the pancreas, which can be benign or malignant. Pancreatic cancer is particularly aggressive and often diagnosed at an advanced stage.
Pancreatic Cancer: SGM-101 Imaging Study
We are testing a new imaging agent to help surgeons better see pancreatic tumors during surgery. This study aims to improve the accuracy of tumor detection and assess the extent of cancer in patients who have received prior treatment.
3-6 months≤5 visitsEfficacy phase (II)No PlaceboCost ReimbursementInvestigational MedicinesInjectionGastroenterologyInternal MedicineOncology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have borderline resectable or locally advanced pancreatic cancer?
- Are you pregnant or breastfeeding?
- Have you ever had a severe allergic reaction (anaphylaxis)?
- Have you previously received SGM-101?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sgm-101
Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Leids Universitair Medisch Centrum (LUMC)
Surgery
Leiden, Netherlands
Sponsor: Academisch Ziekenhuis Leiden
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.